Skip to main content icon/video/no-internet

In 1964, the surgeon general issued the first Report on Smoking and Health to review and evaluate the health consequences of tobacco use. Since that landmark report, tobacco has become increasingly recognized as the leading cause of preventable illness and death in our society. Tobacco use is directly linked to cancers, cardiovascular disease, pulmonary disease, stroke, and pregnancy complications. According to the Centers for Disease Control and Prevention, smoking accounts for more than 435,000 deaths and an estimated $193 billion in direct and indirect medical costs each year in the United States. Despite the well-known health risks and cost of smoking, approximately 21% of U.S. adults still smoke tobacco products, and an additional 3% currently use smokeless tobacco products. It is estimated that each day about 4,000 adolescents between the ages of 12 and 17 will try their first cigarette. Many of them will develop lifelong dependency for tobacco.

Understanding tobacco dependence as a chronic, biopsychosocial disease is important for prevention and treatment. There is no doubt that psychosocial pressures influence the initiation oftobacco use, but it is the reinforcement and dependency produced by nicotine in the brain that fuels the addiction. Understanding the physiological effects of tobacco, and especially nicotine, is helpful in identifying specific populations at risk for dependence as well as in the development of effective pharmacological therapies.

Pharmacology of Tobacco

Tobacco and its by-product, tobacco smoke, contain hundreds of physiologically active and psychoactive compounds, each with differing effect on the human body. Nicotine is the chemical in tobacco that is chiefly responsible for producing the reinforcing effects responsible for smoking dependence and is likely responsible for similar dependency in smokeless (spit) tobacco. It is also responsible for many of the somatic and subjective effects observed by the tobacco user.

Pharmacology of Nicotine

Nicotine is a naturally occurring chemical found in the tobacco plant. It absorbs easily through the lungs, the lining of the mouth, the skin, and, to a lesser extent, the gastrointestinal tract. Nicotine quickly distributes through the bloodstream and easily crosses the blood-brain barrier, allowing it to act directly on the brain. The dose and bioavailability of nicotine (fraction of administered dose reaching systemic circulation unchanged) depends on the method by which nicotine is delivered to the body.

The average cigarette contains 6 to 11 milligrams (mg) of pure nicotine of which only a fraction, 1 to 3 mg, enters into the bloodstream. The bioavailability of nicotine can be increased up to threefold depending on the inhalation technique of the smoker. In comparison, the nicotine absorbed from the average dose of smokeless tobacco is equivalent to three to four cigarettes.

Nicotine from tobacco smoke is quickly absorbed through the lungs and distributed throughout the body. It is estimated that nicotine from smoked tobacco reaches the brain within seven seconds of inhalation. The nicotine found in smokeless tobacco is absorbed through the buccal membranes of the mouth and through the small intestine if tobacco juices are swallowed. Although both smoked tobacco and smokeless tobacco have similar peak concentrations in the venous blood, the absorption of nicotine from smokeless tobacco occurs much more slowly than that of smoked tobacco. Consequently, smokeless tobacco has a longer duration of effect which may persist for some time after the tobacco is removed.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading